What is NON RARE IN EUROPE: Psoriatic arthritis?
Psoriatic arthritis (PsA) is a condition that causes joint pain, swelling, and stiffness in people who also have psoriasis, a skin disease that causes red, scaly patches. It is sometimes called PsA for short. The disease happens when the immune system mistakenly attacks healthy joints and skin, causing inflammation. This inflammation can affect any joint in the body, but it most commonly targets the fingers, toes, spine, and the joints where tendons and ligaments attach to bone. Psoriatic arthritis can range from mild to severe. Some people have only a few affected joints, while others experience widespread joint damage that can affect their ability to move and do everyday tasks. The skin symptoms of psoriasis often appear before the joint problems, sometimes by many years. However, in some people, joint symptoms come first or appear at the same time as the skin disease. Treatment has improved greatly in recent years. There are many options available, including anti-inflammatory medicines, disease-modifying drugs, and newer biologic therapies that target specific parts of the immune system. While there is no cure, many people with psoriatic arthritis are able to manage their symptoms well and live active lives with the right treatment plan.
Key symptoms:
Joint pain, swelling, and tendernessMorning stiffness that improves with movementSwollen fingers or toes that look like sausages (dactylitis)Red, scaly skin patches (psoriasis)Nail changes such as pitting, thickening, or separation from the nail bedPain and swelling where tendons or ligaments attach to bone (enthesitis), especially the heelLower back or buttock pain and stiffnessFatigue and low energyEye redness or pain (uveitis)Reduced range of motion in affected jointsJoint warmth and redness
- Inheritance
- Multifactorial
- Caused by a mix of several genes and environmental factors
- Age of Onset
- Adult
- Begins in adulthood (age 18 or older)
FDA & Trial Timeline
10 eventsChia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. — PHASE2
UCB Biopharma SRL — PHASE1
Second Affiliated Hospital, School of Medicine, Zhejiang University
Novartis Pharmaceuticals — NA
Shanghai Yueyang Integrated Medicine Hospital
Hansoh BioMedical R&D Company — PHASE2
Izmir Katip Celebi University — NA
Ankara City Hospital Bilkent
Cairo University
Bristol-Myers Squibb — PHASE3
Data is compiled from FDA regulatory filings and ClinicalTrials.gov, then processed through automated extraction; event classifications and dates may occasionally be misclassified. Verify against the linked FDA filing or trial record before clinical decisions. Updated periodically.
Treatments
Source: openFDA + DailyMed · NDA / BLA labels with structured indications · refreshed weekly
No FDA-approved treatments are currently listed for NON RARE IN EUROPE: Psoriatic arthritis.
11 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Source: ClinicalTrials.gov · synced daily · phases, status, and PI names normalized at ingest
Specialists
View all specialists →Source: NPI Registry + PubMed · trial PI roles cross-referenced with ClinicalTrials.gov · ranked by match score (publications + PI activity + community signal)
No specialists are currently listed for NON RARE IN EUROPE: Psoriatic arthritis.
Treatment Centers
8 centersSource: NORD Rare Disease Centers + NIH Undiagnosed Diseases Network (UDN) · centers verified active within last 12 months
Children's Hospital Colorado Rare Disease Program ↗
Children's Hospital Colorado
📍 Aurora, CO
👤 Boston Children's Hospital Rare Disease Program
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDBoston Children's Hospital Rare Disease Program ↗
Boston Children's Hospital
📍 Boston, MA
👤 Boston Children's Hospital Rare Disease Program
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
🏨 Children'sAnn & Robert H. Lurie Children's Hospital Genetics ↗
Lurie Children's Hospital
📍 Chicago, IL
👤 Boston Children's Hospital Rare Disease Program
🏥 NORDCincinnati Children's Hospital Medical Center ↗
Cincinnati Children's
📍 Cincinnati, OH
👤 Boston Children's Hospital Rare Disease Program
🏨 Children'sNationwide Children's Hospital Rare Disease Center ↗
Nationwide Children's Hospital
📍 Columbus, OH
👤 Boston Children's Hospital Rare Disease Program
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
Travel Grants
No travel grants are currently matched to NON RARE IN EUROPE: Psoriatic arthritis.
Community
No community posts yet. Be the first to share your experience with NON RARE IN EUROPE: Psoriatic arthritis.
Start the conversation →Latest news about NON RARE IN EUROPE: Psoriatic arthritis
Source: PubMed + NIH RePORTER + openFDA + clinical-journal RSS · last 30 days · disease-tagged at ingest by AI extraction with human QC
No recent news articles for NON RARE IN EUROPE: Psoriatic arthritis.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Which joints are affected and how much damage has already occurred?,What treatment do you recommend for me, and why?,How will we know if the treatment is working, and how long before I see results?,What are the risks and side effects of the medications you are recommending?,Should I be screened for related conditions like heart disease or diabetes?,Are there lifestyle changes — such as diet or exercise — that can help my symptoms?,What should I do if I have a flare, and when should I contact you urgently?
Common questions about NON RARE IN EUROPE: Psoriatic arthritis
What is NON RARE IN EUROPE: Psoriatic arthritis?
Psoriatic arthritis (PsA) is a condition that causes joint pain, swelling, and stiffness in people who also have psoriasis, a skin disease that causes red, scaly patches. It is sometimes called PsA for short. The disease happens when the immune system mistakenly attacks healthy joints and skin, causing inflammation. This inflammation can affect any joint in the body, but it most commonly targets the fingers, toes, spine, and the joints where tendons and ligaments attach to bone. Psoriatic arthritis can range from mild to severe. Some people have only a few affected joints, while others experi
How is NON RARE IN EUROPE: Psoriatic arthritis inherited?
NON RARE IN EUROPE: Psoriatic arthritis follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does NON RARE IN EUROPE: Psoriatic arthritis typically begin?
Typical onset of NON RARE IN EUROPE: Psoriatic arthritis is adult. Age of onset can vary across affected individuals.
Are there clinical trials for NON RARE IN EUROPE: Psoriatic arthritis?
Yes — 11 recruiting clinical trials are currently listed for NON RARE IN EUROPE: Psoriatic arthritis on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Frequently asked questions about NON RARE IN EUROPE: Psoriatic arthritis
Auto-generated from canonical disease facts (Orphanet, OMIM, ClinicalTrials.gov, openFDA, NPPES). Not a substitute for clinical guidance.
What is NON RARE IN EUROPE: Psoriatic arthritis?
NON RARE IN EUROPE: Psoriatic arthritis is a rare disease catalogued in international rare-disease ontologies (Orphanet ORPHA:40050). It is typically inherited as multifactorial. Age of onset is generally adult. For verified primary sources, see the UniteRare NON RARE IN EUROPE: Psoriatic arthritis page.
How is NON RARE IN EUROPE: Psoriatic arthritis inherited?
NON RARE IN EUROPE: Psoriatic arthritis follows multifactorial inheritance. Genetic counseling is recommended for affected families to understand recurrence risk in offspring and the likelihood of unaffected siblings being carriers. Variants in the underlying gene(s) may be identified via clinical genetic testing.
Are there FDA-approved treatments for NON RARE IN EUROPE: Psoriatic arthritis?
Approved treatments for NON RARE IN EUROPE: Psoriatic arthritis are tracked from openFDA and DailyMed primary sources. Many rare diseases have no specific FDA-approved therapy; for those, supportive care and management of complications form the basis of clinical care. Orphan-drug-designation status is noted where applicable.
Are there clinical trials recruiting for NON RARE IN EUROPE: Psoriatic arthritis?
UniteRare currently lists 11 clinical trials relevant to NON RARE IN EUROPE: Psoriatic arthritis sourced from ClinicalTrials.gov. Each trial entry includes recruitment status, eligibility criteria summary, principal-investigator information, and study locations. Patients should discuss eligibility with their healthcare provider before enrolling.
How do I find a specialist for NON RARE IN EUROPE: Psoriatic arthritis?
Verified NON RARE IN EUROPE: Psoriatic arthritis specialists are identified through ClinicalTrials.gov principal-investigator records, peer-reviewed publication authorship (via PubMed), and the NPPES NPI registry. NORD-designated Centers of Excellence and NIH-affiliated rare-disease clinics are also tracked. UniteRare's specialist directory is updated continuously as new evidence becomes available.
See full NON RARE IN EUROPE: Psoriatic arthritis page for complete clinical details, sources, and verified-specialist listings.
Cite this page
Select a citation format above to view and copy.